Get to know our clinical trials

Phase 3, global, multicenter, randomized, double-blind, double-blind, controlled clinical trial with Propofol to evaluate the efficacy and safety of HSK3486 injectable emulsion in the induction of general anesthesia in adults undergoing elective surgery

THE OBJECTIVE OF THIS CLINICAL TRIAL IS TO LEARN ABOUT THE SAFETY AND EFFICACY (HOW WELL A DRUG WORKS) OF THE CLINICAL TRIAL DRUG (HSK3486) COMPARED TO PROPOFOL IN PATIENTS UNDERGOING SCHEDULED SURGERY WITH GENERAL ANESTHESIA USING ENDOTRACHEAL INTUBATION (IE).

Status
In recruitment
headquarters
Pamplona

Technical Summary

  • PHASE 3, GLOBAL, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-BLIND, CONTROLLED CLINICAL TRIAL WITH PROPOFOL TO EVALUATE THE EFFICACY AND SAFETY OF HSK3486 INJECTABLE EMULSION IN THE INDUCTION OF GENERAL ANESTHESIA IN ADULTS UNDERGOING ELECTIVE SURGERY
  • Code EudraCT: 2023-507009-32-00
  • Protocol number: HSK3486-309
  • Promoter: Haisco Usa Pharmaceuticals Inc
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.